# Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

> **NCT00188929** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 10 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

- **PROCEDURE:** PET Scan with [18F]Fluoro-2-deoxyglucose (FDG)

## Key facts

- **NCT ID:** NCT00188929
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188929, "Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00188929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*